<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="366934">
  <stage>Registered</stage>
  <submitdate>19/08/2014</submitdate>
  <approvaldate>3/09/2014</approvaldate>
  <actrnumber>ACTRN12614000942651</actrnumber>
  <trial_identification>
    <studytitle>Metformin versus insulin in the management of diabetes mellitus in pregnancy </studytitle>
    <scientifictitle>Metformin versus insulin in the management of diabetes mellitus in pregnancy at the Korle Bu Teaching Hospital</scientifictitle>
    <utrn>U1111-1160-5026

</utrn>
    <trialacronym>MIS</trialacronym>
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Diabetes Mellitus in pregnancy.</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Arm 1: metformin only; starting dose 500mg taken orally twice daily and increased gradually every 2 weeks to a maximum dose of 2500mg or till optimum glycaemic control is attained. Treatment begins from enrolment till delivery.
Arm 2: insulin only; starting total daily dose of insulin is 0.3-1.0 i.u/kg body weight depending on glycaemic profile at diagnosis. This is titrated up to achieve optimum glycaemic control. Total daily dose of premixed insulin is divided into 2: 2/3 administered 30 min before breakfast and 1/3 administered 30 minutes before supper. insulin is administered subcutaneously in the deltoid region. 
Insulin is administered from enrolment till delivery.
Arm 3: metformin +insulin for failures on arm 1 
Failures on arm 1 means worsening glycaemic profile on OGTT i.e. fasting blood glucose greater 7.0 mmol/l or 2-hour post glucose greater 11.0 mmol/l after maximum dose adjustment.
Dose and duration of metformin and insulin in this arm is the same as their respective doses and durations in arms 1 and 2. Titration to higher doses is more aggressives to ensure strict control of glycaemic profile.
Adherence is monitored tablet and drug return on review visit
</interventions>
    <comparator>Standard treatment:this is the same as the treatment in arm 2 above. starting total daily dose of insulin is 0.3-1.0 i.u/kg body weight depending on glycaemic profile at diagnosis. This is titrated up to achieve optimum glycaemic control. Total daily dose of premixed insulin is divided into 2: 2/3 administered 30 min before breakfast and 1/3 administered 30 minutes before supper. insulin is administered subcutaneously in the deltoid region.
For diabetic emergencie such diabetic ketoacidosis or when Fasting blood glucose is found at any time to be higher than 13.0 mmol/l subjects are admitted and managed on sliding scale with soluble insulin. in very severe cases the modified Alberti's  regimen is used to rapidly reduce blood glucose levels. Before discharge, the total daily dose of soluble insulin is converted to premixed insulin and administered twice daily as above.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>2 hour blood glucose level in oral glucose tolerance test. </outcome>
      <timepoint>At baseline, one  month after enrollment and at 37 weeks gestation.  </timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Maternal weight gain. It is measured with a calibrated analogue scale - Seca 'registered trade mark' (gmbh&amp;Co. Kg Germany)</outcome>
      <timepoint>Baseline to 37 weeks gestation.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Pregnant with single fetus at gestational age of 20 to 30 weeks and have been diagnosed with Type 2 DM or Gestational Diabetes</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>45</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>patients with pre-gestational diabetes mellitus who require insulin to achieve glycaemic control and patients with contra-indications to metformin therapy</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed opaque envelopes</concealment>
    <sequence>Simple randomization using Balloting</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/01/2013</anticipatedstartdate>
    <actualstartdate>2/01/2013</actualstartdate>
    <anticipatedenddate>31/10/2013</anticipatedenddate>
    <actualenddate>27/10/2013</actualenddate>
    <samplesize>104</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Ghana</country>
      <state>Greater Accra Region</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr. Titus Beyuo</primarysponsorname>
    <primarysponsoraddress>Department of Obstetric and Gynaecology, 
Korle Bu Teaching Hospital, 
P O Box KB77
korle Bu, Accra. </primarysponsoraddress>
    <primarysponsorcountry>Ghana</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Dr. Titus Beyuo</fundingname>
      <fundingaddress>Department of Obstetric and Gynaecology, 
Korle Bu Teaching Hospital, 
P O Box KB77
korle Bu, Accra. </fundingaddress>
      <fundingcountry>Ghana</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The objective of this study was to determine if either metformin monotherapy or metformin in combination with insulin is equally effective as insulin monotherapy at glycaemic control in diabetes mellitus in pregnancy among Ghanaians</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Ethical and Protocol Review committee of the University of Ghana Medical School </ethicname>
      <ethicaddress>University of Ghana Medical School
P O Box 4236
Accra</ethicaddress>
      <ethicapprovaldate>21/12/2012</ethicapprovaldate>
      <hrec>MS-Et/M.4 â€“ P3.3/2012-13 </hrec>
      <ethicsubmitdate />
      <ethiccountry>Ghana</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Titus Beyuo</name>
      <address>Department of Obstetric and Gynaecology, 
Korle Bu Teaching Hospital, 
P O Box KB77
korle Bu, Accra. </address>
      <phone>+233 200284332</phone>
      <fax />
      <email>drbeyuo@gmail.com</email>
      <country>Ghana</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Titus Beyuo</name>
      <address>Department of Obstetric and Gynaecology, 
Korle Bu Teaching Hospital, 
P O Box KB77
korle Bu, Accra. </address>
      <phone>+233 200284332</phone>
      <fax />
      <email>drbeyuo@gmail.com</email>
      <country>Ghana</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Titus Beyuo</name>
      <address>Department of Obstetric and Gynaecology, 
Korle Bu Teaching Hospital, 
P O Box KB77
korle Bu, Accra. </address>
      <phone>+233 200284332</phone>
      <fax />
      <email>drbeyuo@gmail.com</email>
      <country>Ghana</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Titus Beyuo</name>
      <address>Department of Obstetric and Gynaecology, 
Korle Bu Teaching Hospital, 
P O Box KB77
korle Bu, Accra. </address>
      <phone>+233 200284332</phone>
      <fax />
      <email>drbeyuo@gmail.com</email>
      <country>Ghana</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>